XORTX Therapeutics (XRTX) Total Liabilities (2020 - 2026)
XORTX Therapeutics (XRTX) posted Total Liabilities of $860988.0 for Q1 2026, up 43.72% on a QoQ basis from $599071.0 in Q4 2025, and up 13.68% year-over-year from $757350.0 in Q1 2025.
XORTX Therapeutics (XRTX) Total Liabilities (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Total Liabilities history runs 7 years deep, the most recent figure standing at $860988.0 for Q1 2026.
- Quarterly Total Liabilities rose 13.68% year-over-year to $860988.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $860988.0 (up 13.68% YoY) and the FY2025 annual result came in at $599071.0, down 20.97% from the prior year.
- Total Liabilities was $860988.0 for Q1 2026 at XORTX Therapeutics, up from $599071.0 in the prior quarter.
- Across five years, Total Liabilities topped out at $5.4 million in Q4 2022 and bottomed at $403262.0 in Q2 2023.
- A 5-year average of $1.8 million and a median of $849198.0 in 2025 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities tumbled 86.47% — and 2024, when it soared 493.46%.
- XORTX Therapeutics' Total Liabilities stood at $5.4 million in 2022, then slumped by 89.68% to $553757.0 in 2023, then soared by 36.88% to $757990.0 in 2024, then decreased by 20.97% to $599071.0 in 2025, then soared by 43.72% to $860988.0 in 2026.
- Business Quant data shows XRTX's Total Liabilities at $860988.0 in Q1 2026, $599071.0 in Q4 2025, and $837408.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 177.22 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 19.51 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 3.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 753.82 Mn |
| 10 | XORTX Therapeutics | 2.91 Bn | 2.91 Bn | - | 860,988.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 860,988.00 |
| Dec 31, 2025 | 599,071.00 |
| Sep 30, 2025 | 837,408.00 |
| Jun 30, 2025 | 711,455.00 |
| Mar 31, 2025 | 757,350.00 |
| Dec 31, 2024 | 757,990.00 |
| Sep 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 2.09 Mn |
| Mar 31, 2024 | 3.56 Mn |
| Sep 30, 2023 | 553,757.00 |
| Jun 30, 2023 | 403,262.00 |
| Mar 31, 2023 | 599,788.00 |
| Dec 31, 2022 | 5.37 Mn |
| Sep 30, 2022 | 3.26 Mn |
| Jun 30, 2022 | 2.98 Mn |
| Mar 31, 2022 | 3.98 Mn |
| Dec 31, 2021 | 4.20 Mn |
| Sep 30, 2021 | 9.59 Mn |
| Dec 31, 2020 | 793,297.91 |